                         SEQUENCE LISTING

<110>  Agency for Science, Technology and Research
 
<120>  CANCER SPECIFIC ANTIGEN BINDING PROTEINS

<130>  9869SG3542

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody Clone

<400>  1

Gln Val Lys Leu Gln Gln Ser Gly Pro Gly Leu Val Ala Pro Ser Gln 
1               5                   10                  15      


Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Arg Tyr 
            20                  25                  30          


Gly Val Tyr Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Gly Val Ile Trp Ala Val Gly Ser Thr Asn Tyr Asn Ser Ala Leu Met 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Lys Asp Lys Ser Lys Ser Gln Val Phe Leu 
65                  70                  75                  80  


Lys Met Asn Ser Leu Gln Thr Asp Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Arg Glu Tyr Gly Tyr Gly Leu Ala Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210>  2
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody Clone

<400>  2

Asp Ile Glu Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Ile 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Ser Thr Ser Pro Lys Leu Trp Ile Tyr 
        35                  40                  45              


Asp Thr Ser Asn Leu Ala Ser Gly Val Pro Gly Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Asn Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu 
65                  70                  75                  80  


Asp Val Ala Thr Tyr Tyr Cys Phe Gln Gly Ser Gly Tyr Pro Leu Thr 
                85                  90                  95      


Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 
            100                 105     


<210>  3
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  3
caggtcaaac tgcagcagtc aggacctggc ctggtggcgc cctcacagag cctgtccatc       60

acttgcactg tctctggatt ttcattaagc agatatggtg tatattgggt tcgccagcct      120

ccaggaaagg gtctggagtg gctgggagta atatgggcgg ttggaagcac aaattataat      180

tcggctctca tgtccagact gagcatcagc aaagacaagt ccaagagtca agttttctta      240

aaaatgaaca gtctgcaaac tgatgacaca gccatgtact actgtgcccg agatagagag      300

tacggctacg ggcttgctta ctggggccaa gggaccacgg tcaccgtctc ctca            354


<210>  4
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  4
gacattgagc tcacccagtc tccagcaatc atgtctgcat ctccagggga aaaggtcacc       60

atgacctgca gtgccagctc aagtgtaagt tacatacact ggtaccagca gaagtcaagc      120

acctccccca aactctggat ttatgacaca tccaacctgg cttctggagt cccaggtcgc      180

ttcagtggca gtgggtctgg aaactcttac tctctcacga tcagcagcat ggaggctgaa      240

gatgttgcca cttattactg ttttcagggg agtgggtacc cgctcacgtt cggtgctggg      300

accaagctgg agctgaaac                                                   319


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  5

Gly Phe Ser Leu Ser Arg Tyr Gly Val Tyr 
1               5                   10  


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  6

Val Ile Trp Ala Val Gly Ser Thr Asn Tyr Asn Ser Ala Leu Met Ser 
1               5                   10                  15      


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  7

Asp Arg Glu Tyr Gly Tyr Gly Leu Ala Tyr 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  8

Ser Ala Ser Ser Ser Val Ser Tyr Ile His 
1               5                   10  


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  9

Asp Thr Ser Asn Leu Ala Ser 
1               5           


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  10

Phe Gln Gly Ser Gly Tyr Pro Leu Thr 
1               5                   


<210>  11
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  11
ggattttcat taagcagata tggtgtatat                                        30


<210>  12
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  12
gtaatatggg cggttggaag cacaaattat aattcggctc tcatgtcc                    48


<210>  13
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  13
gatagagagt acggctacgg gcttgcttac                                        30


<210>  14
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  14
agtgccagct caagtgtaag ttacatacac                                        30


<210>  15
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  15
gacacatcca acctggcttc t                                                 21


<210>  16
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Antibody clone

<400>  16
tttcagggga gtgggtaccc gctcacg                                           27


<210>  17
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer sequence

<400>  17
ccacaatact ccaccaatga cctta                                             25


<210>  18
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer sequence

<400>  18
cccattttaa gtggctccac ctctc                                             25


